Deans' stroke musings

Changing stroke rehab and research worldwide now.Time is Brain!Just think of all the trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It's quite disgusting that this information is not available from every stroke association and doctors group.
My back ground story is here:http://oc1dean.blogspot.com/2010/11/my-background-story_8.html

Wednesday, May 31, 2017

CVD remains main cause of death worldwide

No mention that maybe stopping the 5 causes of the neuronal cascade of death in the first week would substantially reduce the 30-day stroke deaths.
http://www.healio.com/cardiology/chd-prevention/news/online/%7B6d94a822-3d48-42fc-b5e0-7499310831e4%7D/cvd-remains-main-cause-of-death-worldwide?utm_source=selligent&utm_medium=email&utm_campaign=cardiology%20news&m_bt=592835816269
One-third of all deaths worldwide are attributed to CVD such as stroke and heart diseases, even with declines in the past 25 years due to sociodemographic changes, according to a study in the Journal of the American College of Cardiology.
“It is an alarming threat to global health,” Gregory A. Roth, MD, MPH, assistant professor of cardiology at the University of Washington in Seattle, said in a press release. “Trends in CVD mortality are no longer declining for high-income regions, and low- and middle-income countries are also seeing more CVD-related deaths.”
Data analysis
Researchers analyzed data from 133 countries from 1990 to 2015. Ten different causes of CVD-related deaths were reviewed, including ischemic stroke, ischemic heart disease, and hemorrhagic and other stroke.
Disability-adjusted life-years were also analyzed, which combined data on years of life lost and years lived with disability. The researchers developed a sociodemographic index to measure changes in CVD burden as global epidemiologic changes occurred.
An estimated 422.7 million cases of CVD were seen globally in 2015 (95% uncertainty interval [UI], 415.53 million-427.87 million). CVD-related deaths increased from 12.59 million in 1990 (95% UI, 12.38 million-12.8 million) to 17.92 million in 2015 (95% UI, 17.59 million-18.28 million).
After age adjustment, numerous countries did not show significant changes in the prevalence of CVD from 1990 to 2015, which may have been due to minimal data availability. CVD significantly declined after age adjustment in countries such as the United States, Canada, Australia, Brazil, Japan, New Zealand, South Korea, Cambodia, Kenya, India, Laos and those in Western Europe. CVD mortality typically declined in high-income regions, but has leveled out recently, according to the researchers.

Perspective

Ian J. Neeland
  • These findings provide a much-needed global perspective on CVD prevalence and mortality. It is striking that although CVD mortality rates have generally declined in the last decade in the United States, this seems to be a phenomenon limited to well-developed, high-income populations. Most of the world, including Central Asia and Oceania, continue to have a significant burden of mortality related to CVD. These findings should spur the medical community to look outside of our own “home” and refocus our efforts on battling the global public health burden of CVD.
    Better access to health care and lifesaving and sustaining treatments, especially for those in disadvantaged regions, is certainly one strategy that can help reverse the negative trends in the developing world.
    Obesity, which is growing to be a global epidemic rather than just one localized to North America or well-developed countries, is probably the No. 1 health concern that will slow down our progress in prevention and treatment of CVD. Poor nutrition and lack of physical activity continue to be problems in the modern era of technology and fast food. These major risk factors for obesity will continue to drive the obesity epidemic, especially in the developing world.
    • Ian J. Neeland, MD, FAHA
    • Cardiology Today Next Gen Innovator
      University of Texas Southwestern Medical Center, Dallas

No comments:

Post a Comment